A possible therapeutic strategy to treat DMD is the delivery of a dystrophin transgene to cells through a viral vector such as lentivirus [94], adenovirus [95] or adeno-associated virus (AAV). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.